Spider Rock Advisors, LLC Amarin Corp Plcuk Put Options Transaction History

Spider Rock Advisors, LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2020 Jan 28, 2021	SELL	$4.04 - $5.31 $30,300 - $39,825	-7,500 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$4.78 - $8.26 $35,850 - $61,950	-7,500 Reduced 50.0%	7,500 $34,000
Q1 2020 May 11, 2020	SELL	$4.0 - $21.53 $160,400 - $863,353	-40,100 Reduced 72.78%	15,000 $72,000
Q4 2019 Jan 17, 2020	BUY	$13.94 - $24.12 $104,550 - $180,900	7,500 Added 15.76%	55,100 $10,000
Q3 2019 Oct 28, 2019	SELL	$13.89 - $23.16 $416,700 - $694,800	-30,000 Reduced 38.66%	47,600 $69,000
Q2 2019 Jul 29, 2019	SELL	$16.27 - $20.51 $309,130 - $389,690	-19,000 Reduced 19.67%	77,600 $83,000
Q1 2019 May 15, 2019	BUY	$12.61 - $22.33 $1.22 Million - $2.16 Million	96,600 New	96,600 $179,000

176

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $254M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Spider Rock Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Spider Rock Advisors, LLC with notifications on news.